ARCHIVES

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

This article is from The Cancer Letter archive.

Vol. 18 No. 14 | April 3, 1992

Download PDF Visit The Full Archive

Related Articles

Dingell To Challenge NCI, NSABP Handling Of Fraud, Delays

April 8, 1994

New Drug Reduces Nausea and Vomiting

October 31, 2003

DeVita Suggest “Overlay Consortium” as Outreach Mechanism for Southern California, Other Areas

September 28, 1984

The Cancer Letter Wins Awards (12-page issue).

June 13, 2003

In Brief: NCAB To Meet Jan. 15-17; UCLA To Compete For Clinical Neutron Therapy Contract

January 5, 1979

High-Priority Radiation Therapy Research Projects Approved By DCT Board of Counselors

March 26, 1976